Status:
COMPLETED
A Single-centre Research Study to Evaluate the Care4Today® Heart Failure Platform.
Lead Sponsor:
Buckinghamshire Healthcare NHS Trust
Collaborating Sponsors:
Janssen-Cilag Ltd.
Conditions:
Heart Failure With Reduced Ejection Fraction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A research study to evaluate the impact of a novel care pathway for patients diagnosed with Heart Failure within Chiltern CCG, supported by an integrated clinical patient record. Assessment of patient...
Detailed Description
This is an exploratory study to evaluate the impact of the novel Care4Today HF platform on a set of outcomes including hospital admission rate (primary diagnosis), 30 days post discharge readmission r...
Eligibility Criteria
Inclusion
- Adults 18 years of age or older with the primary diagnosis of heart failure
- Must have moderate to severe LVSD (ejection fraction \<= 40%) confirmed by an echocardiogram and/or other cardiac imaging
Exclusion
- Patients with right heart failure as a consequence of respiratory disease
- Patients with Heart Failure with preserved Ejection Fraction
- Patients with significant learning disability, or severe mental health conditions
- Patients with metabolic heart disease e.g. amyloid
- Patients with severe non-operable valve disease
Key Trial Info
Start Date :
May 18 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2018
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT04371731
Start Date
May 18 2015
End Date
April 4 2018
Last Update
May 1 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.